Skip to content
Application 020928
- Type
- NDA
- Sponsor
- LILLY
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | GLUCAGON | GLUCAGON | INJECTABLE;INJECTION | 1MG/VIAL | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0002-8031 | Glucagon | glucagon | Eli Lilly and Company | NDA | Current |
| 0002-8031 | Glucagon | glucagon | Eli Lilly and Company | NDA | Current |
| 0002-8031 | Glucagon | glucagon | Eli Lilly and Company | NDA | Current |
| 0002-8031 | Glucagon | glucagon | Eli Lilly and Company | NDA | Current |
| 0002-8031 | Glucagon | glucagon | Eli Lilly and Company | NDA | Current |
| 0002-8031 | Glucagon | glucagon | Eli Lilly and Company | NDA | Current |
| 50090-0639 | Glucagon | glucagon | A-S Medication Solutions | NDA | Current |
| 63323-582 | Glucagon | Glucagon | Fresenius Kabi USA, LLC | NDA | Current |
| 64725-8031 | Glucagon | glucagon | TYA Pharmaceuticals | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 66086 | SUPPL | 2021-02-03 |
| 66006 | SUPPL | 2021-01-27 |
| 56965 | SUPPL | 2018-12-21 |
| 54858 | SUPPL | 2018-07-09 |
| 54865 | SUPPL | 2018-07-06 |
| 53764 | SUPPL | 2018-04-20 |
| 53738 | SUPPL | 2018-04-19 |
| 35654 | SUPPL | 2004-04-05 |
| 26211 | SUPPL | 2004-02-25 |
| 41816 | ORIG | 1998-09-11 |
| 26210 | ORIG | 1998-09-11 |
| 13750 | ORIG | 1998-09-11 |